List of Tables
    Table 1. Medical Cannabis CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Medical Cannabis Market Trends
    Table 3. Medical Cannabis Market Drivers
    Table 4. Medical Cannabis Market Challenges
    Table 5. Medical Cannabis Market Restraints
    Table 6. Global Medical Cannabis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Medical Cannabis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Medical Cannabis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Medical Cannabis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Medical Cannabis Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Medical Cannabis Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Medical Cannabis Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Medical Cannabis Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Medical Cannabis Sales Share by Manufacturer, 2017-2022
    Table 15. Global Medical Cannabis Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Medical Cannabis Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Medical Cannabis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Cannabis as of 2021)
    Table 18. Top Players of Medical Cannabis in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Medical Cannabis Product Type
    Table 20. Date of International Manufacturers Enter into Medical Cannabis Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Medical Cannabis Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Medical Cannabis Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Medical Cannabis Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Medical Cannabis Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Medical Cannabis Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Medical Cannabis Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Medical Cannabis Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Medical Cannabis Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Medical Cannabis Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Medical Cannabis Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Medical Cannabis Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Medical Cannabis Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. BOL Pharma Corporation Information
    Table 43. BOL Pharma Description and Business Overview
    Table 44. BOL Pharma Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. BOL Pharma Medical Cannabis Product
    Table 46. BOL Pharma Recent Development
    Table 47. Tilray Corporation Information
    Table 48. Tilray Description and Business Overview
    Table 49. Tilray Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Tilray Product
    Table 51. Tilray Recent Development
    Table 52. Medreleaf Corporation Corporation Information
    Table 53. Medreleaf Corporation Description and Business Overview
    Table 54. Medreleaf Corporation Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Medreleaf Corporation Product
    Table 56. Medreleaf Corporation Recent Development
    Table 57. Aurora Cannabis, Inc Corporation Information
    Table 58. Aurora Cannabis, Inc Description and Business Overview
    Table 59. Aurora Cannabis, Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Aurora Cannabis, Inc Product
    Table 61. Aurora Cannabis, Inc Recent Development
    Table 62. Canopy Growth Corporation Corporation Information
    Table 63. Canopy Growth Corporation Description and Business Overview
    Table 64. Canopy Growth Corporation Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Canopy Growth Corporation Product
    Table 66. Canopy Growth Corporation Recent Development
    Table 67. Insys Therapeutics, Inc Corporation Information
    Table 68. Insys Therapeutics, Inc Description and Business Overview
    Table 69. Insys Therapeutics, Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Insys Therapeutics, Inc Product
    Table 71. Insys Therapeutics, Inc Recent Development
    Table 72. Aphria, Inc Corporation Information
    Table 73. Aphria, Inc Description and Business Overview
    Table 74. Aphria, Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Aphria, Inc Product
    Table 76. Aphria, Inc Recent Development
    Table 77. MGC Pharmaceuticals Limited Corporation Information
    Table 78. MGC Pharmaceuticals Limited Description and Business Overview
    Table 79. MGC Pharmaceuticals Limited Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. MGC Pharmaceuticals Limited Product
    Table 81. MGC Pharmaceuticals Limited Recent Development
    Table 82. GW Pharmaceuticals, plc Corporation Information
    Table 83. GW Pharmaceuticals, plc Description and Business Overview
    Table 84. GW Pharmaceuticals, plc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. GW Pharmaceuticals, plc Product
    Table 86. GW Pharmaceuticals, plc Recent Development
    Table 87. Medical Marijuana Inc Corporation Information
    Table 88. Medical Marijuana Inc Description and Business Overview
    Table 89. Medical Marijuana Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Medical Marijuana Inc Product
    Table 91. Medical Marijuana Inc Recent Development
    Table 92. Medipharm Labs Corporation Information
    Table 93. Medipharm Labs Description and Business Overview
    Table 94. Medipharm Labs Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Medipharm Labs Product
    Table 96. Medipharm Labs Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Medical Cannabis Customers List
    Table 100. Medical Cannabis Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Medical Cannabis Product Picture
    Figure 2. Global Medical Cannabis Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Medical Cannabis Market Size 2017-2028 (US$ Million)
    Figure 4. Global Medical Cannabis Sales 2017-2028 (MT)
    Figure 5. United States Medical Cannabis Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Medical Cannabis Market Size 2017-2028 (US$ Million)
    Figure 7. United States Medical Cannabis Sales 2017-2028 (MT)
    Figure 8. United States Medical Cannabis Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Medical Cannabis Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Medical Cannabis Report Years Considered
    Figure 11. Product Picture of Tetrahydrocannabinol (THC)
    Figure 12. Product Picture of Cannabidiol (CBD)
    Figure 13. Global Medical Cannabis Market Share by Type in 2022 & 2028
    Figure 14. Global Medical Cannabis Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Medical Cannabis Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Medical Cannabis Sales by Type (2017-2028) & (MT)
    Figure 17. Global Medical Cannabis Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Medical Cannabis Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Medical Cannabis Market Share by Type in 2022 & 2028
    Figure 20. United States Medical Cannabis Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Medical Cannabis Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Medical Cannabis Sales by Type (2017-2028) & (MT)
    Figure 23. United States Medical Cannabis Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Medical Cannabis Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of Pain
    Figure 26. Product Picture of Arthritis
    Figure 27. Product Picture of Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
    Figure 28. Product Picture of Others
    Figure 29. Global Medical Cannabis Market Share by Application in 2022 & 2028
    Figure 30. Global Medical Cannabis Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Medical Cannabis Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Medical Cannabis Sales by Application (2017-2028) & (MT)
    Figure 33. Global Medical Cannabis Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Medical Cannabis Price by Application (2017-2028) & (USD/MT)
    Figure 35. United States Medical Cannabis Market Share by Application in 2022 & 2028
    Figure 36. United States Medical Cannabis Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Medical Cannabis Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Medical Cannabis Sales by Application (2017-2028) & (MT)
    Figure 39. United States Medical Cannabis Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Medical Cannabis Price by Application (2017-2028) & (USD/MT)
    Figure 41. North America Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 42. North America Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 46. Europe Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 53. Asia-Pacific Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 65. Latin America Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 70. Middle East & Africa Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Medical Cannabis Value Chain
    Figure 75. Medical Cannabis Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed